Cargando…
Three Innovations of Next-Generation Antibiotics: Evolvability, Specificity, and Non-Immunogenicity
Antimicrobial resistance is a silent pandemic exacerbated by the uncontrolled use of antibiotics. Since the discovery of penicillin, we have been largely dependent on microbe-derived small molecules to treat bacterial infections. However, the golden era of antibiotics is coming to an end, as the eme...
Autor principal: | Shim, Hyunjin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9952447/ https://www.ncbi.nlm.nih.gov/pubmed/36830114 http://dx.doi.org/10.3390/antibiotics12020204 |
Ejemplares similares
-
Next Generation BTK Inhibitors in CLL: Evolving Challenges and New Opportunities
por: Frustaci, Anna Maria, et al.
Publicado: (2023) -
Time to evolve: predicting engineered T cell-associated toxicity with next-generation models
por: Donnadieu, Emmanuel, et al.
Publicado: (2022) -
Next-Generation Influenza HA Immunogens and Adjuvants in Pursuit of a Broadly Protective Vaccine
por: Nagashima, Kaito A., et al.
Publicado: (2021) -
The Evolving Role of Next-Generation Sequencing in Screening and Diagnosis of Hemoglobinopathies
por: Achour, Ahlem, et al.
Publicado: (2021) -
Incentivising innovation in antibiotic drug discovery and development: progress, challenges and next steps
por: Simpkin, Victoria L, et al.
Publicado: (2017)